Product Details
DOVATO Dolutegravir Sodium / Lamivudine 50 mg - 30 mg Tablet Bottle 30 Tablets
Manufacturer: VIIV HEALTHCARE
MFG#: 49702-0246-13
NDC: 49702-0246-13
PID: 350419
Additional Information
| Product Name | Dovato Dolutegravir Sodium / Lamivudine 50 Mg - 30 Mg Tablet Bottle 30 Tablets |
| Application | HIV Integrase Inhibitor and Nucleoside Reverse Transcriptase Inhibitor (NRTI) |
| Generic Drug Name | Dolutegravir Sodium / Lamivudine |
| Mechanism of Action | Dolutegravir inhibits integrase, while lamivudine inhibits reverse transcriptase |
| Strength | 50 mg - 30 mg |
| Dosage Form | Tablet |
| Administration | Oral, once daily with or without food |
| Side Effects | Headache, nausea, diarrhea, fatigue, liver enzyme abnormalities, hypersensitivity reactions |
| Precautions | Monitor for liver function, hypersensitivity reactions, and potential drug interactions |
| Adherence | Once-daily dosing improves patient adherence compared to multiple daily doses |
| Container Type | Bottle |
| Quantity | 30 Tablets |
| Indications | HIV-1 infection in adults, used as a complete regimen or part of combination therapy |
Description
Dovato (Dolutegravir Sodium / Lamivudine) 50 mg - 30 mg tablets are a fixed-dose combination used for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults. This combination regimen consists of dolutegravir, an integrase strand transfer inhibitor (INSTI), and lamivudine, a nucleoside reverse transcriptase inhibitor (NRTI). Both drugs work synergistically to inhibit critical steps in the HIV life cycle, preventing the virus from replicating and helping to maintain viral suppression.
Dolutegravir functions by binding to the HIV integrase enzyme, preventing the integration of viral DNA into the host genome. Lamivudine works by inhibiting reverse transcriptase, preventing the conversion of viral RNA into DNA. The combination of these two agents offers potent and effective suppression of HIV replication.
Each bottle contains 30 tablets, with each tablet providing 50 mg of dolutegravir and 30 mg of lamivudine. Common side effects may include headache, diarrhea, nausea, and fatigue. Serious side effects include hypersensitivity reactions and liver enzyme abnormalities. Dovato should be stored at room temperature, away from moisture and light.
Frequently Asked Questions (FAQs)
The cost of DOVATO Dolutegravir Sodium / Lamivudine 50 mg - 30 mg Tablet Bottle 30 Tablets is $available for registerd members only
DOVATO Dolutegravir Sodium / Lamivudine 50 mg - 30 mg Tablet Bottle 30 Tablets is manufactured by VIIV HEALTHCARE.
You can purchase DOVATO Dolutegravir Sodium / Lamivudine 50 mg - 30 mg Tablet Bottle 30 Tablets on our website at https://supplies.pipelinemedical.com/product/detail/dovato-dolutegravir-sodium-and-lamivudine-tablet-film-coated-350419